Brown, Tyler D. http://orcid.org/0000-0003-1752-2174
Whitehead, Kathryn A. http://orcid.org/0000-0002-0100-7824
Mitragotri, Samir http://orcid.org/0000-0002-2459-8305
Article History
Accepted: 24 October 2019
First Online: 24 December 2019
Change Date: 8 January 2020
Change Type: Update
Change Details: The originally published article contained a typographical error in the final text box of Figure 1, which has been corrected in the HTML and PDF versions of the manuscript.
Competing interests
: S.M. declares that he is a shareholder and director of i2O Therapeutics, which is developing oral-drug-delivery products based on ionic liquids, and acts as a consultant and as a member of the advisory board of Entrega Bio. T.D.B. declares that he is a shareholder and employee of i2O Therapeutics. K.A.W. declares no competing interests.